Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

46.10
+0.31000.68%
Volume:212.74K
Turnover:9.80M
Market Cap:1.46B
PE:28.36
High:46.66
Open:45.79
Low:45.53
Close:45.79
52wk High:50.79
52wk Low:23.23
Shares:31.61M
Float Shares:28.09M
Volume Ratio:0.74
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.63
EPS(LYR):1.86
ROE:22.96%
ROA:6.75%
PB:5.30
PE(LYR):24.83

Loading ...

Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Dec 30, 2025

Major Issues Report

Form 8-K - Current report
Dec 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 07, 2025

Major Issues Report

Form 8-K - Current report
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities